Anna Vassall is a Professor of Health Economics at the London School of Hygiene and Tropical Medicine (LSHTM) and holds the Joep Lange Chair at the Amsterdam Institute of Global Health and Development at the University of Amsterdam. She is a health economist with over twenty-five years of both professional and academic experience in economic analysis in low and middle-income countries. Anna leads the economic evaluation and priority setting group in the Department of Global Health at LSHTM. Her work focuses on the economics of HIV, sexual and reproductive health, gender-based violence prevention and tuberculosis (TB). She has led a wide range of economic analyses on HIV prevention for key populations (Avahan programme), the integration and organisation of HIV care and treatment services (Integra project), and new diagnostics for TB (Xpert MTB/RIF). She has an interest in incorporating a health systems and the patient perspective into economic evaluation and priority setting.
She is a founding member of the TB-MAC modeling consortium and sits on the Strategic and Technical Advisory Group for the WHO’s Global TB Programme (STAG-TB) and Task Force on Catastrophic Cost Measurement for TB. She is a lead investigator of the Global Health Costing Consortium; a Bill and Melinda Gates funded project to estimate and analyse HIV, TB and other health service costs globally.